- ABRAHAM , J. 1994 . Negotiation and accommodation in expert medical risk assessment and regulation: an institutional analysis of the benoxaprofen case . Policy Sciences , 27 : 53 – 76 .
- ABRAHAM , J. 1995 . Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation , London : UCL Press/Taylor & Francis .
- ABRAHAM , J. and LEWIS , G. 2000 . Regulating Medicines in Europe: Competition, Expertise and Public Health , London : Routledge .
- ABRAHAM , J. and SHEPPARD , J. 1999 . The Therapeutic Nightmare: The Baffle Over the World's Most Controversial Sleeping Pill , London : Earthscan .
- ANON . 1991 . ICH--backroom politics, front-line science . Scrip , 1669 15 November : 18 – 20 .
- ANON . 1992a . ICH progress so far . Scrip , 1707 8 April : 14 – 15 .
- ANON . 1992b . WHO stresses interest in ICH . Scrip , 1708 10 April : 16
- ANON . 1993 . ICH2--status of tripartite harmonisation initiatives . Scrip , 1872 12 November : 19
- ANON . 1994 . ICH--preparing for Brussels . Scrip , 1963 4 October : 18 – 19 .
- ANON . 1995 . Product liability outlook in Japan . Scrip , 1992 20 January : 22
- ANON . 1996 . Trust--PhRMA's biggest challenge . Scrip , 2123 26 April : 13
- ANON . 1997a . ICH 'common technical document" . Scrip , 2246 4 July : 16
- ANON . 1997b . 'Too many me-toos" in EC . Scrip , 2287 25 November : 2
- ANON . 2000 . ICH progress on single dossier . Scrip , 2522 15 March : 17
- ARAGA , Y. 'Keynote address" . Proceedings of the Third International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- BANGEMANN , M. Welcome and Introduction: Welcome address by Mr Martin Bangemann, VicePresident of the Commission of the European Communities . Proceedings of the First International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- BROWN , J.S. , KAITIN , K.I. , McAUSLANE , N. , THOMAS , K.E. and WALKER , S.R. 1996 . Population exposure required to assess clinical safety: report to the ICH working group . Drug Information Journal , 30 : 17 – 27 .
- CECCHINI , P. 1988 . The European Challenge, 1992 , Aldershot : Wildwood House .
- CLAUDE , J.R. 1993 . Six months before ICH2: an overview on the harmonisation of the guidelines on toxicology . Comparative Haematology International , 3 : 174 – 177 .
- DAVIS , P. 1997 . Managing Medicines: Public Policy and Therapeutic Drugs , Buckingham : Open University Press .
- DEBOYSER , P. A common technical document for applications . Proceedings of the Fourth International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- FERRIS , M.J. 1992 . “ A review of the Japanese regulatory system ” . In Medicines: Regulation, Research and Risk , Edited by: GRIFFIN , J.P. Belfast : Queen's University Press .
- FLETCHER , P. 1990 . “ What can be learnt by examining the data in the files of regulatory authorities? ” . In Animal Toxicity Studies: Their Relevance f or Man , Edited by: LUMLEY , C.E. and WALKER , S.R. Lancaster : Quay Publishing .
- GARUTTI , R.J. Clinical safety data management: definitions and standards for expedited reporting . Proceedings of the Second International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- GIAQUINTO , A. A common technical document for applications . Proceedings of the Fourth International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- GORDON , A.J. Clinical safety data management ICH guideline recommendations and reasoning . Proceedings of the Second International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- HALLIDAY , R.G. , DRASDO , A.L. , LUMLEY , C.E. and WALKER , S.R. 1997 . The allocation of resources for R&D in the world's leading pharmaceutical companies . R&D Management , 27 : 63 – 77 .
- HODGKIN , C. 1996 . International harmonisation-the need for transparency . International Journal of Risk & Safety in Medicine , 9 : 195 – 199 .
- ICH . 27 October 1994a . “ Guideline on the Extent of Population Exposure to Assess Clinical Safety for Drugs Intended for Long-term Treatment of Non-life-threatening Conditions ” . 27 October ,
- ICH . 27 October 1994b . “ Clinical Safety Data Management: Definitions & Standards for Expedited Reporting ” . 27 October ,
- ICH . 29 November 1995 . “ Guideline on the Need for Carcinogenicity Studies of Phannaceuncals ” . 29 November ,
- ICH . 6 November 1996 . “ Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs ” . 6 November ,
- ICH . 16 July 1997 . “ Duration of Chronic Toxicity Testing in Animals ” . 16 July ,
- IFPMA . 1998 . “ A brief history of ICH ” . In ICH: Past and Future at
- IFPMA . 2000 . The Value and Benefits of ICH to Industry , IFPMA .
- MclNTYRE , A. 1999 . Key Issues in the Pharmaceutical Industry , Chichester : John Wiley .
- MICOSSI , S. Impact and implementation: regulatory perspectives . Proceedings of the Fourth International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- NAITO , H. The influence of harmonisation on industry strategies and relations between industry and regulators . Proceedings of the Fourth International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- NAKAJIMA , H. The ICH programme: accomplishments and impact on world health . Proceedings of the Third International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- NIGHTINGALE , S.L. Impact and implementation: regulatory perspectives (USA) . Proceedings of the Fourth International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- OKUNO , I. Clinical safety data management: definitions and standards for expedited reporting-Japanese industry's perspectives . Proceedings of the Second International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- POGGIOLINI , D. Research development and regulation: a background to harmonization . Proceedings of the First International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- REED-MAURER , P. 1994 . Restructuring the Japanese pharmaceutical industry . Scrip Magazine , May : 38 – 40 .
- Ross , C. 1994a . Japan's medical information transparency . Lancet , 343 4 June : 1418 – 1419 .
- Ross , C. 1994b . New drug approval process under scrutiny . Lancet , 344 15 October : 1075 – 1076 .
- SCALES , M.D.C. Safety: review of present guidelines' . Proceedings of the Third International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- SJOBERG , P. Data to support the extension of clinical trials . Proceedings of the Third International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- SMITH-HOLSTON , S. The implications of harmonisation: viewpoint from the USA . Proceedings of the Third International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- TANSEY , I.P. , ARMSTRONG , N.A. and WALKER , S.R. 1994 . 'Trends in Pharmaceutical Innovation: The Introduction of Products on to the UK Market, 1960-1989 . Journal of Pharmaceutical Medicine , 4 : 85 – 100 .
- WEISSINGER , J. 'Safety: discussion' . Proceedings of the First International Conference on Harmonisation . Belfast. Edited by: D'ARCY , P.P. and HARRON , D.W.G. IFPMA .
- WYATT-WALTER , A. 1995 . Globalisation, corporate identity and European technology policy . Journal of European Public Policy , 2 : 427 – 446 .
Health, Risk & Society
Volume 3, 2001 - Issue 1
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112448/MPU-L1SN.png"})